Definitive Healthcare financials
$0.9300+1.61%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $55.2M | $55.9M | $61.5M | $60.0M | $60.8M | $59.2M | $62.3M | $62.7M | $63.7M | $63.5M | $65.9M | $65.3M |
| Gross profit | $40.5M | $41.6M | $46.9M | $46.0M | $46.6M | $43.8M | $47.6M | $49.0M | $50.5M | $50.4M | $53.4M | $53.4M |
| Gross margin | 73.5% | 74.5% | 76.2% | 76.6% | 76.7% | 73.9% | 76.4% | 78.2% | 79.2% | 79.4% | 81.0% | 81.8% |
| Operating income | -$6.7M | -$201.3M | -$26.6M | -$8.7M | -$4.2M | -$184.8M | -$99.6M | -$225.4M | -$369.6M | -$16.2M | -$10.1M | -$295.4M |
| Net income | -$5.4M | -$138.6M | -$9.3M | -$14.8M | -$7.6M | -$107.2M | -$59.1M | -$130.9M | -$213.6M | -$9.5M | -$10.2M | -$171.5M |
| Net margin | −9.8% | −247.9% | −15.1% | −24.7% | −12.4% | −181.2% | −94.8% | −208.8% | −335.2% | −15.0% | −15.5% | −262.6% |
| Diluted EPS | $-0.05 | $-1.32 | $-0.09 | $-0.14 | $-0.07 | $-0.95 | $-0.51 | $-1.12 | $-1.81 | $-0.08 | $-0.09 | $-1.50 |
| EBITDA | $12.8M | $12.2M | $11.1M | $14.7M | $14.8M | $10.8M | $17.4M | $17.8M | $13.5M | $8.7M | -$8.3M | $12.0M |
| Operating cash flow | $11.5M | $11.6M | $2.7M | $15.7M | $9.3M | $26.1M | $8.1M | $19.4M | $14.0M | $16.6M | $4.7M | $9.5M |
| Free cash flow | $8.5M | $8.4M | -$1.7M | $13.4M | $7.0M | $18.4M | -$2.8M | $18.7M | $13.6M | $16.3M | $4.1M | $9.2M |
| Diluted shares | 105.8M | 104.7M | 103.2M | 103.8M | 106.8M | 112.8M | 115.0M | 116.4M | 117.8M | 117.4M | 116.5M | 114.5M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $170.9M | $157.6M | $163.6M | $108.3M | $81.0M | $106.1M |
| Short-term investments | $12.7M | $20.4M | $17.3M | $77.6M | $103.2M | $94.6M |
| Total debt | $160.6M | $162.7M | $164.8M | $166.9M | $169.0M | $171.1M |
| Total assets | $496.8M | $514.7M | $735.5M | $755.5M | $770.1M | $808.7M |
| Total liabilities | $309.0M | $324.0M | $356.5M | $365.9M | $358.9M | $372.8M |
| Shareholders' equity | $187.9M | $190.7M | $379.0M | $389.7M | $411.2M | $435.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology